science and Innovation Board daily on the 14th, today’s science and Innovation Board evening news mainly includes: according to the data of China Automobile Association, the sales volume of new energy vehicles in December 2021 was 531000, a year-on-year increase of 1.1 times; LG Innotek seeks to reach a camera supply agreement worth hundreds of billions of won with Tesla; Asahi biological announced that the company’s relevant covid-19 testing products have obtained the EU CE certification, which is a non exclusive risk.
newsletter:
[hotspot Focus]
Ten departments including the Ministry of industry and information technology: encourage the incubation and transformation of scientific and technological innovation achievements in the eastern region in the central, Western and northeast regions
Ten departments including the Ministry of industry and information technology issued guidance on promoting the orderly transfer of manufacturing industry. The opinions puts forward three modes to meet the needs of the modernization of industrial chain and supply chain, combined with the actual situation of industrial transfer. First, promote the upstream and downstream docking cooperation mode of the industrial chain supply chain, and create a competitive industrial chain supply chain ecosystem. Second, innovate the inter regional industrial transfer cooperation mode, and support the eastern region to support the development of the central, Western and northeast regions through trusteeship and co construction. Third, explore the cross regional transfer and cooperation mode of scientific and technological achievements, and encourage the incubation and transformation of scientific and technological innovation achievements in the eastern region in the central, Western and northeast regions.
China Automobile Association: 531000 new energy vehicles were sold in December 2021, a year-on-year increase of 1.1 times
According to the data of China Automobile Association, in December 2021, the production and sales of new energy vehicles were 518000 and 531000 respectively, with a year-on-year increase of 1.2 times and 1.1 times respectively, and the market penetration rate was 19.1%. From January to December, the production and sales of new energy vehicles were 3.545 million and 3.521 million respectively, an increase of 1.6 times year-on-year, and the market penetration rate was 13.4%, an increase of 8 percentage points year-on-year.
Andon Health Co.Ltd(002432) : the U.S. government has the right to terminate the contract at any time due to its own factors
Andon Health Co.Ltd(002432) by issuing the supplementary announcement, the U.S. government has the right to terminate the contract at any time due to its own factors. The above meaning means that the U.S. government can request to stop the execution of the contract without any reason and cancel the subsequent procurement. The Seller shall bear the corresponding risks and possible losses. In addition, the company replied to the letter of concern of Shenzhen Stock Exchange. At present, the company has obtained the authorization of the U.S. FDA EUA and can be sold in the United States, but it has not obtained the Chinese license and cannot be put into use in China.
it is said that LG energy and Honda jointly built a battery plant in the United States, with an annual capacity of 40gwh
LG energy solution, a local battery manufacturer in South Korea, plans to establish a battery factory for electric vehicles in the United States with a maximum investment of 4 trillion won (about US $3.36 billion) and an annual production capacity of 40gwh.
LG Innotek seeks to reach a camera supply agreement worth hundreds of billions of won with Tesla
According to sources, LG Innotek seeks to reach a supply agreement with Tesla (tsla. O) on cameras and parts. The transaction is worth hundreds of billions of won. At that time, Tesla modely, Model3, electric truck semi and cybertruck to be launched in North America and Europe will be equipped with cameras produced by LG Innotek.
[announcement of science and innovation board]
a number of science and Innovation Board companies announced the pre increased performance in 2021
According to the announcement of Zhuzhou Huarui Precision Cutting Tools.Co.Ltd(688059) , the net profit in 2021 is expected to be RMB 157 million-167 million, with a year-on-year increase of 76.39% to 87.63%.
According to the announcement of Hangzhou Alltest Biotech Co.Ltd(688606) , the net profit in 2021 is expected to be 705-795 million yuan, with a year-on-year increase of 3.78% – 17.05%, and the covid-19 testing business maintains a stable growth.
According to the announcement of Shanghai Bright Power Semiconductor Co.Ltd(688368) , the net profit in 2021 is expected to be RMB 660 million-680 million, with a year-on-year increase of 858% – 887%. The downstream demand of the industry where the company’s LED lighting driver chip is located is strong.
According to the announcement of Zhejiang Orient Gene Biotech Co.Ltd(688298) , the net profit in 2021 is expected to be 4.72 billion yuan – 5.12 billion yuan, a year-on-year increase of 181.45% – 205.31%; The sales performance of New Coronavirus antigen rapid test reagent (including family self testing) products in the European market continued to increase significantly, prompting a substantial increase in operating performance in 2021.
According to the announcement of Hangzhou Biotest Biotech Co.Ltd(688767) , the net profit in 2021 is expected to be 810-910 million yuan, with a year-on-year increase of 86.14% to 109.12%. Affected by Delta, Omicron and other variants of covid-19 virus, the number of covid-19 infection cases in Europe, Australia and other countries and regions continued to increase significantly, and the demand for covid-19 antigen detection reagent increased significantly, which directly led to the significant growth of the company’s overseas covid-19 detection reagent revenue.
China Chippacking Technology Co.Ltd(688216) released the annual performance forecast for 2021. It is estimated that the annual operating revenue in 2021 will reach 790 million yuan to 820 million yuan, an increase of 242 million yuan to 272 million yuan, a year-on-year increase of 44.16% to 49.63%. It is estimated that in 2021, the net profit attributable to the owners of the parent company will reach 126 million yuan to 140 million yuan, an increase of 45.63 million yuan to 59.63 million yuan, a year-on-year increase of 56.77% to 74.19%.
Asahi biology: the company’s relevant covid-19 testing products have obtained EU CE certification, non exclusive risk
An Xu bio released serious abnormal volatility announcement of stock trading. New Coronavirus SARS-CoV-2Antigen self testing reagent (self testing reagent Rapid Tests for self-testing) and New Coronavirus antigen nasal cavity reagent (self test) (COVID-19Antigen Nasal Test Kit) were granted EU CE certification in recent years, and the time of obtaining the certificate was relatively late. The above product certification is not exclusive to the company. There are similar products or other testing products in the market, and the company’s products will still face the risk of fierce market competition.
Beijing Hotgen Biotech Co.Ltd(688068) : the company’s covid-19 antigen self-test reagent product has not obtained the U.S. market access certification
Beijing Hotgen Biotech Co.Ltd(688068) issued the announcement of the alteration, the company’s New Coronavirus antigen self testing reagent product has obtained the EU CE certification and the British MHRA and France ANSM self testing registration / filing, has not yet obtained the US market access certification, and there are many similar or other testing products in the European market, the company’s products will face fierce market competition risk.
Affected by many factors such as overseas epidemic development and epidemic prevention and control policies, market competition, path selection of international epidemic on technical products, product competitiveness and channel ability of the company, customer recognition and so on, the sales and profit contribution of the above covid-19 products are relatively uncertain.
Shenzhen Yhlo Biotech Co.Ltd(688575) : it is proposed to launch the restricted stock incentive plan in 2022
Shenzhen Yhlo Biotech Co.Ltd(688575) announced the restricted stock incentive plan (Draft) for 2022. The number of restricted shares to be granted in the incentive plan is 2 million shares, accounting for about 0.49% of the total share capital of the company.
Rayitek Hi-Tech Film Company Ltd.Shenzhen(688323) : it is proposed to issue convertible bonds and raise no more than 430 million yuan to invest in Jiaxing high-performance polyimide film project
Rayitek Hi-Tech Film Company Ltd.Shenzhen(688323) it is announced that the total amount of funds raised by the company to issue convertible bonds shall not exceed 430 million yuan. After deducting the issuance expenses, the net amount of funds raised is planned to be invested in Jiaxing high-performance polyimide film project, supplement working capital and repay bank loans.
[issuance and approval status]
update of issuance and approval status of 1 company to be listed on the science and innovation board
As of press time, a total of 713 companies’ applications for listing on the science and innovation board have been accepted, and the issuance and approval status of one company has been updated. Yuneng technology has been inquired.
[venture capital vane]
Denglin technology completes a new round of strategic financing
High performance AI computing technology and market enterprise Denglin technology announced the completion of a new round of strategic financing. This round of financing was continuously supported by Qualcomm venture capital and Guangyuan capital, and jointly completed by particle future, qinglinghuayu, silicon port capital, Qianhui intelligent investment, leading enterprises in China’s information industry and old shareholders.
micro intelligence completed tens of millions of yuan pre-A round of financing
Jinan Micro Intelligent Technology Co., Ltd., a special light imaging company, announced the completion of tens of millions of yuan pre-A round of financing, led by GT venture capital and followed by Zhenghai investment. The amount of this round of financing will be used for the R & D and registration of the company’s new products, academic marketing and team expansion.
Darwin biology completes round a + financing
Beijing Darwin Cell Biotechnology Co., Ltd. announced the completion of the a + round of RMB 130 million financing. The financing is led by the National SME development fund sub fund managed by qingkong ginkgo and followed by Jinan Lantian Investment Co., Ltd.
Baihai technology completed tens of millions of Yuan seed round financing
Cloud native AI development and production tool “Baihai technology” announced the completion of tens of millions of Yuan seed round financing, led by Zhenzhi capital. This round of financing will be mainly used for the accelerated development, improvement and promotion of AI intelligent development platform IDP.
